Sapient

Overview

Sapient is a contract research organization specializing in multi-omics services for biomarker discovery and validation. The company bridges discovery and clinical decision-making by uncovering functional protein and metabolite biomarkers that elucidate disease biology, mechanism of action, and responder profiles.

Core Services

Omics Platforms:

• Discovery and targeted proteomics (>12K off-the-shelf assays; tumor protein mapping; PTM and proteoform analysis)
• Metabolomics and lipidomics (>15K metabolites and lipids per sample; in-house library of >13K standards)
• Cytokine profiling (NULISAseq inflammation panels with 340+ biomarkers; CNS disease panels with 220+ biomarkers; mouse panels)
• Multi-omics integrated studies

Analytical & Computational:

• High-throughput mass spectrometry with robust QC monitoring
• AI-enabled computational pipeline for spectral processing and metabolite identification
• DynamiQ Insights Engine for biocomputational analysis and biological contextualization
• Multi-scale analyses integrating molecular, phenotypic, and clinical data
• Preclinical-to-clinical translation via real-world cohort validation

Regulatory & Quality:

• GCLP-compliant workflows for assays supporting clinical trials (WHO GCLP guidance compliance)
• Rapid turnaround across all development phases
• Expert-guided insights delivery with integrated biological narratives

Differentiation

Sapient positions itself as the only multi-omics partner to analyze samples and confirm findings in real-world cohorts. The DynamiQ molecular-clinical database integrates omics data across all layers and grounds insights in human evidence, enabling clients to move from data to breakthroughs in weeks rather than months.